SUSTAINED PROTECTION FROM PENTAVALENT ROTAVIRUS VACCINATION DURING THE SECOND YEAR OF LIFE AT A LARGE, URBAN UNITED STATES PEDIATRIC HOSPITAL

Authors:
  • JTJacqueline E. Tate
    Jacqueline E. Tate
  • LSLeila C. Sahni
    Leila C. Sahni
  • MRMarcia A. Rench
    Marcia A. Rench
  • SMSlavica Mijatovic-Rustempasic
    Slavica Mijatovic-Rustempasic
  • MPManish M. Patel
    Manish M. Patel
  • CBCarol J. Baker
    Carol J. Baker
  • UPUmesh D. Parashar
    Umesh D. Parashar

Abstract
Fecal specimens from children presenting to Texas Children's Hospital with acute gastroenteritis were tested for the presence of rotavirus. Children were grouped according to vaccination status, and pentavalent rotavirus vaccine effectiveness was calculated. Pentavalent rotavirus vaccine effectiveness against severe rotavirus gastroenteritis was sustained during the first 2 years of the vaccination program. Overall 3-dose effectiveness was 83% to 86%; it was 92% to 93% among children 6 to 11 months of age and 78% to 84% among children ≥12 months of age.

This publication has 15 references indexed in Scilit: